1E Therapeutics

1E Therapeutics (previously known as Hanako) is a breakthrough drug development company based in Israel. They are creating a novel class of programmable oligonucleotide therapeutics, designed to treat humanity’s most intractable diseases by autonomously and precisely silencing disease-causing RNAs in human or pathogen cells.